跳至主要内容
临床试验/DRKS00030106
DRKS00030106已完成未知

Formation and uptake of specialized pro-resolving lipid mediators from a synbiotic, omega-3 fatty-acid food supplement: a double-blind, randomized, placebo-controlled parallel design with healthy subjects

Evonik Operations GmbH0 个研究点目标入组 72 人开始时间: 2022年9月6日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
72

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomized controlled study
盲法
Blinded (masking used)

入排标准

年龄范围
30 Years 至 75 Years(—)
性别
All

入选标准

  • (1) Women and men with low habitual consumption of fatty fish and seafood, defined as a frequency of twice per month or less (minimum 25% of each gender)
  • (2) BMI: 19-35 kg/m²
  • (3) Omega-3 index in erythrocytes: = 6.0 % at screening
  • (4) Classification as at-risk individual” according to AGE (advanced glycation end products) reader
  • (5) hsCRP level = 1 mg/L at screening visit
  • (6) Non-smoker
  • (7) Subject is in good physical and mental health as established by medical history, physical examination, vital signs, results of biochemistry, haematology
  • (8) Written consent to participate in the study
  • (9) Able and willing to follow the study procedures

排除标准

  • (1) Relevant history or presence of any severe medical disorder, potentially interfering with this study (e.g. mal absorption, chronic gastro-intestinal diseases, heavy depression, diabetes, acute cancers within last 3 years except basal cell carcinoma of the skin, etc.)
  • (2) Subject under prescription for medication or taking dietary supplements possibly interfering with this study (such as omega-3 fatty acids, probiotics, anti-spasmodic, laxatives and anti-diarrheic drugs or other digestive auxiliaries, use of PPIs, bismuth salts and/or H2-antagonists, fibers, chronic intake of NSAR or acetylsalicylic acid, glucocorticoids etc.) within 2 weeks prior to study start or during the study
  • (3) Intake of antibiotics in the last 2 months and laxatives in the last 2 weeks
  • (4) Significant changes in lifestyle or medication (within last 2 months) or surgical intervention or surgical procedure such as bariatric surgery
  • (5) Vegans
  • (6) Subjects consuming
  • food or drinks claimed as ‘probiotic’ more than once weekly
  • (7) Subjects with stool frequency of = 2 stools per week
  • (8) Subjects with history of drug, alcohol or other substance abuse, or other factors limiting their ability to co-operate during the study
  • (9) Relevant allergy or known hypersensitivity against compounds of the study preparations (e.g. fish)
  • (10) Participation in another clinical study within the last 4 weeks and concurrent participation in another clinical study
  • (11) Anticipating any planned changes in lifestyle or physical activity levels for the duration of the study
  • (12) Not willing to abstain on fish consumption or foods / oils high in omega-3 fatty acids, e.g. linseed oil etc.
  • (13) If female: currently pregnant, planning to become pregnant during the study period, breastfeeding (a pregnancy test will be conducted during screening and visits 1 and 3)
  • (14) Subjects considered inappropriate for the study by investigators, including subjects who are unable or unwilling to show compliance with the protocol

研究者

相似试验